首页> 美国卫生研究院文献>Wiley-Blackwell Online Open >A double-blind randomized study comparing the effects of continuing or not continuing rosiglitazone + metformin therapy when starting insulin therapy in people with Type 2 diabetes

【2h】

A double-blind randomized study comparing the effects of continuing or not continuing rosiglitazone + metformin therapy when starting insulin therapy in people with Type 2 diabetes

机译：一项双盲随机研究比较了2型糖尿病患者开始胰岛素治疗时持续或不持续使用罗格列酮+二甲双胍治疗的效果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

AimsTo compare the efficacy and safety of either continuing or discontinuing rosiglitazone + metformin fixed-dose combination when starting insulin therapy in people with Type 2 diabetes inadequately controlled on oral therapy.

机译：目的比较在口服治疗控制不充分的2型糖尿病患者中开始胰岛素治疗时比较持续或停用罗格列酮+二甲双胍固定剂量联合治疗的疗效和安全性。

著录项

期刊名称 Wiley-Blackwell Online Open
作者
P D Home; C J Bailey; J Donaldson; H Chen; M W Stewart;
展开▼
作者单位

展开▼
年(卷),期 -1(24),6
年度 -1
页码 618–625
总页数 8
原文格式 PDF
正文语种
中图分类
关键词
insulin metformin randomized controlled trial thiazolidinediones Type 2 diabetes mellitus;

机译：胰岛素;二甲双胍;随机对照试验;噻唑烷二酮;2型糖尿病;

相似文献

外文文献
中文文献
专利

1. Effect of the addition of rosiglitazone to metformin or sulfonylureas versus metformin/sulfonylurea combination therapy on ambulatory blood pressure in people with type 2 diabetes: A randomized controlled trial (the RECORD study) [J] . Michel Komajda, Paula Curtis, Markolf Hanefeld, Cardiovascular Diabetology . 2008,第1期

机译：罗格列酮与二甲双胍或磺脲类药物联合二甲双胍/磺脲类药物联合治疗对2型糖尿病患者动态血压的影响：一项随机对照试验（RECORD研究）
2. A randomized, parallel group, double-blind, multicentre study comparing the efficacy and safety of Avandamet (rosiglitazone/metformin) and metformin on long-term glycaemic control and bone mineral density after 80 weeks of treatment in drug-naive type 2 diabetes mellitus patients. [J] . Borges JL, Bilezikian JP, Jones Leone AR, Diabetes, obesity & metabolism . 2011,第11期

机译：一项随机，平行，双盲，多中心，多中心研究，比较了未经药物治疗的2型糖尿病患者在治疗80周后，Avandamet（罗格列酮/二甲双胍）和二甲双胍对长期血糖控制和骨矿物质密度的有效性和安全性。
3. Rosiglitazone/metformin fixed-dose combination compared with uptitrated metformin alone in type 2 diabetes mellitus: a 24-week, multicenter, randomized, double-blind, parallel-group study. [J] . Bailey CJ, Bagdonas A, Rubes J, Clinical therapeutics . 2005,第10期

机译：在2型糖尿病患者中，罗格列酮/二甲双胍固定剂量的组合与单独使用二甲双胍的剂量相比：一项为期24周，多中心，随机，双盲，平行组的研究。
4. Comparing artificial pancreas controlled by hybrid "closed-loop" machine learning (ML) trained algorithm to multi-daily injection (MDI), insulin pump without CGM and "sensor assisted" insulin pump therapies for Diabetes Type 1 (DT1) treatment [C] . Joan Carles Peiró International Conference on Data Analytics for Business and Industry: Way Towards a Sustainable Economy . 2020

机译：将通过混合“闭环”机器学习（ML）控制的人工胰腺培训算法对多日注于多日注射（MDI），胰岛素泵而没有CGM和“传感器辅助”胰岛素泵疗法1型（DT1）处理
5. Metformin as an adjunct to insulin therapy in adolescents with type 1 diabetes: A pilot study. [D] . Hamilton, Jill Krysti. 2002

机译：二甲双胍作为1型糖尿病青少年胰岛素治疗的辅助药物：一项初步研究。
6. Double‐blind randomized clinical trial comparing the efficacy and safety of continuing or discontinuing the dipeptidyl peptidase‐4 inhibitor sitagliptin when initiating insulin glargine therapy in patients with type 2 diabetes: The CompoSIT‐I Study [O] . Ronan Roussel, Santiago Duran‐García, Yilong Zhang, -1

机译：一项双盲随机临床试验比较了在2型糖尿病患者中开始胰岛素甘精胰岛素治疗时继续或终止二肽基肽酶-4抑制剂西他列汀的疗效和安全性：CompoSIT-I研究
7. A double-blind randomized study comparing the effects of continuing or not continuing rosiglitazone + metformin therapy when starting insulin therapy in people with Type 2 diabetes1 [O] . Home, P D, Bailey, C J, Donaldson, J, 2007

机译：一项双盲随机研究比较了2型糖尿病患者开始胰岛素治疗时持续或不持续使用罗格列酮+二甲双胍治疗的效果1

A double-blind randomized study comparing the effects of continuing or not continuing rosiglitazone + metformin therapy when starting insulin therapy in people with Type 2 diabetes

摘要

著录项

相似文献

相关主题

期刊订阅